Iwicki Mark T. - 24 Jun 2025 Form 4 Insider Report for KALA BIO, Inc. (KALA)

Reporting relationship: Director
Issuer ticker: KALA
Reported as of: 24 Jun 2025
Net transaction value: -$53,040
SEC form: 4
Accepted by SEC: 26 Jun 2025, 20:00:11 UTC
Prior SEC filing: 17 Jun 2025
Next SEC filing: 14 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Mary Reumuth, Attorney-in-Fact

Key filing fact

Iwicki Mark T. filed Form 4 for KALA BIO, Inc. (KALA) on 26 Jun 2025.

Key facts

This page summarizes Iwicki Mark T.'s Form 4 filing for KALA BIO, Inc. (KALA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 26 Jun 2025, 20:00.

Change

Previous filing in this sequence was filed on 17 Jun 2025.
Current net transaction value: -$53,040.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001415537 Primary reporting owner

Iwicki Mark T

Relationship: Director
Address: C/O KALA BIO, INC., 1167 MASSACHUSETTS AVENUE, ARLINGTON
Signature: /s/ Mary Reumuth, Attorney-in-Fact
Signature date: 26 Jun 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

KALA transaction

Common Stock

Sale

Transaction value: $53,040
Shares: -13,227
Change %: -4.9%
Price: $4.01
Shares after: 258,433
Date: 24 Jun 2025
Ownership: Direct
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

This sale was made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 9, 2020 to cover tax withholding obligations in connection with the vesting and settlement of the Reporting Person's restricted stock units ("RSUs") granted on June 22, 2023.

Footnote F2

The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.87 to $4.12, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

Footnote F3

Includes 103,540 unvested RSUs.